Helix

About:

Helix is a population genomics company that is working to advance genomics research and integrate genomic data into clinical care.

Website: http://www.helix.com

Twitter/X: my_helix

Top Investors: Temasek Holdings, Warburg Pincus, Sutter Hill Ventures, Kleiner Perkins, National Institutes of Health

Description:

Helix is the leading population genomics company working at the intersection of clinical care, research, and genomics. Its end-to-end platform enables health systems, life sciences companies, and payers to advance genomic research and accelerate the integration of genomic data into clinical care. Powered by one of the world's largest CLIA / CAP next-generation sequencing labs and its proprietary Exome+™ assay, Helix supports all aspects of population genomics including recruitment and engagement, clinically actionable disease screening, return of results, and basic and translational research.

Total Funding Amount:

$403M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

San Mateo, California, United States

Founded Date:

2015-07-15

Contact Email:

support(AT)helix.company

Founders:

James Lu, Justin Kao, Scott Burke

Number of Employees:

101-250

Last Funding Date:

2021-06-03

IPO Status:

Private

© 2025 bioDAO.ai